Browsing Category

64799 posts
Fudan MBA Ascends to 27th Position in Global FT Rankings

Fudan MBA Ascends to 27th Position in Global FT Rankings

SHANGHAI, Feb. 26, 2024 /PRNewswire/ — The Financial Times (FT) released its…
MWC 2024: UCLOUDLINK Showcases Innovative Solutions for Better Connection, Empowering Better Life

MWC 2024: UCLOUDLINK Showcases Innovative Solutions for Better Connection, Empowering Better Life

BARCELONA, Spain, Feb. 26, 2024 /PRNewswire/ — At the highly anticipated Mobile…
Ragnarok Landverse Announces Exciting Collaboration with Ultraman

Ragnarok Landverse Announces Exciting Collaboration with Ultraman

SINGAPORE, Feb. 26, 2024 /PRNewswire/ — The moment players have been waiting…
APE 2024: Unveiling the Latest Innovations and Emerging Applications in the Asian Photonics Industry in Singapore

APE 2024: Unveiling the Latest Innovations and Emerging Applications in the Asian Photonics Industry in Singapore

SINGAPORE, Feb. 26, 2024 /PRNewswire/ — Asia Photonics Expo (APE 2024), the…
Group-IB earns Frost & Sullivan's 2024 Competitive Strategy Leadership Award

Group-IB earns Frost & Sullivan's 2024 Competitive Strategy Leadership Award

SINGAPORE, Feb. 26, 2024 /PRNewswire/ — Group-IB, a leading creator of cybersecurity…
H.E. Minister Al-Kaabi announces raising Qatar's LNG production capacity to 142 MTPA before the end of 2030

H.E. Minister Al-Kaabi announces raising Qatar's LNG production capacity to 142 MTPA before the end of 2030

DOHA, Qatar, Feb. 26, 2024 /PRNewswire/ — QatarEnergy has announced that it…
Tencent Cloud Empowers Indonesian Media Group to Deliver Revolutionary Experience with Super App TribunX

Tencent Cloud Empowers Indonesian Media Group to Deliver Revolutionary Experience with Super App TribunX

Tencent Cloud’s cutting-edge solutions take center stage in groundbreaking news and media…
J INTS BIO, Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, accepted for presentation at the upcoming American Association for Cancer Research 2024 meeting in USA (AACR 2024)

J INTS BIO, Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, accepted for presentation at the upcoming American Association for Cancer Research 2024 meeting in USA (AACR 2024)

SEOUL, South Korea, Feb. 26, 2024 /PRNewswire/ — J INTS BIO announced…